Skip to main content
Year archive

Kuros Biosciences Ltd. — 2011 filings

All 10 regulatory filings released by Kuros Biosciences Ltd. (KURN) in 2011, sourced directly from the official regulator.

10 Filings
2011 Period
2011 filings (10)
Filing Released Lang
Cytos Biotechnology Ltd holds a Bondholders' meeting today. Trading of Cytos shares and convertible bonds temporarily suspended.
Regulatory Filings
2011-11-10 English
Cytos Biotechnology Ltd announces Q3 Financial Results and convenes a Bondholders' meeting to secure a going concern
Capital/Financing Update
2011-10-20 English
Cytos Biotechnology Ltd confirms strategic and organizational changes with the aim of preserving value around its lead product and to address the up-coming maturity of the Convertible Bond
Board/Management Information
2011-08-29 English
Cytos Biotechnology Ltd announces strategic and organizational changes with the aim of preserving value around its lead product and to address the up-coming maturity of the Convertible Bond
Regulatory Filings
2011-08-17 English
Cytos Biotechnology Second Quarter Report 2011
Earnings Release H1 2011
2011-07-28 English
Cytos Biotechnology First Quarter Report 2011
Earnings Release Q1 2011
2011-04-28 English
United States Army and Cytos Biotechnology Collaborate on Malaria Vaccines Research
Regulatory Filings
2011-03-31 English
Cytos Biotechnology receives EU funding to work on novel vaccine approaches for emerging viral diseases
Regulatory Filings
2011-02-21 English
Cytos Biotechnology Ltd announces full year 2010 financial results and major developments in 2010
Earnings Release FY 2010
2011-02-17 English
Cytos Biotechnology Presents Latest Data on the Mechanism of Action of QbG10 for the Treatment of Allergic Asthma at the 3rd International Conference on Drug Discovery and Therapy
Regulatory Filings
2011-02-10 English